Deposition of Complement Product C4d in Anti-Glomerular Basement Membrane Glomerulonephritis

American Journal of Kidney Diseases

Volumn 53, Issue 6, 2009, Pages 1098-1101

  Batal, Ibrahim ^a   Chalasani, Geetha ^a   Wu, Christine ^a   Shapiro, Ron ^a   Bastacky, Sheldon ^a   Randhawa, Parmjeet ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anti glomerular basement membrane glomerulonephritis; C4d; recurrence of disease

Indexed keywords

ALEMTUZUMAB; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4D; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; POLYCLONAL ANTIBODY; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANAMNESIS; ARTERIOSCLEROSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; ELECTRON MICROSCOPY; FEMALE; GLOMERULONEPHRITIS; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT; PERITONEAL DIALYSIS; PLASMAPHERESIS; RECURRENT DISEASE; SEROLOGY; URINALYSIS;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; COMPLEMENT C4B; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 65549151686     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.10.008     Document Type: Article

References (22)

1. Colvin R.B. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18 (2007) 1046-1056
2. Feucht H.E., Schneeberger H., Hillebrand G., et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43 (1993) 1333-1338
3. Lederer S.R., Kluth-Pepper B., Schneeberger H., Albert E., Land W., and Feucht H.E. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59 (2001) 334-341
4. Worthington J.E., McEwen A., McWilliam L.J., Picton M.L., and Martin S. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 83 (2007) 398-403
5. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
6. Almkuist R.D., Buckalew Jr. V.M., Hirszel P., Maher J.F., James P.M., and Wilson C.B. Recurrence of anti-glomerular basement membrane antibody mediated glomerulonephritis in an isograft. Clin Immunol Immunopathol 18 (1981) 54-60
7. Deegens J.K., Artz M.A., Hoitsma A.J., and Wetzels J.F. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol 59 (2003) 1-9
8. Khandelwal M., McCormick B.B., Lajoie G., Sweet J., Cole E., and Cattran D.C. Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 19 (2004) 491-494
9. Solez K., Colvin R.B., Racusen L.C., et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8 (2008) 753-760
10. Batal I., Domsic R.T., Shafer A., et al. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol (2008) Oct 28 [Epub ahead of print]
11. Li S.J., Liu Z.H., Zen C.H., Wang Q.W., Wang Y., and Li L.S. Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection. Lupus 16 (2007) 875-880
12. Kalluri R., Wilson C.B., Weber M., Gunwar S., Chonko A.M., and Neilson E.G. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6 (1995) 1178-1185
13. Salama A.D., and Pusey C.D. Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens 11 (2002) 279-286
14. Hellmark T., Johansson C., and Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 46 (1994) 823-829
15. Andres G., Brentjens J., Kohli R., et al. Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes. Kidney Int 13 (1978) 480-491
16. Jennette C., and Nickeleit V. Antiglomerular basement membrane glomerulonephritis and Goodpasture's syndrome. In: Jennette C., Olson J., Schwartz M., and Silva F. (Eds). Heptinstall's Pathology of the Kidney. (ed 6) (2007), Lippincott Williams & Wilkins, Philadelphia, PA 628
17. Border W.A., Baehler R.W., Bhathena D., and Glassock R.J. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91 (1979) 21-25
18. Borza D.B., Chedid M.F., Colon S., Lager D.J., Leung N., and Fervenza F.C. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45 (2005) 397-406
19. Gris P., Pirson Y., Hamels J., Vaerman J.P., Quoidbach A., and Demol H. Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron 58 (1991) 418-424
20. Jayne D.R., Marshall P.D., Jones S.J., and Lockwood C.M. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37 (1990) 965-970
21. Short A.K., Esnault V.L., and Lockwood C.M. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 26 (1995) 439-445
22. Xiao H., Schreiber A., Heeringa P., Falk R.J., and Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170 (2007) 52-64